NCT07323979

Brief Summary

The goal of this randomized controlled trial is to learn if different head-elevated prone positioning angles can optimize cardiopulmonary function and enteral nutrition tolerance in infants and children after congenital heart disease (CHD) surgery. The main questions it aims to answer are:

  1. 1.Do specific prone positioning angles (10°, 30°, or 45°) lead to better improvements in cardiopulmonary recovery, specifically regarding oxygenation, lung compliance, airway resistance, and hemodynamic stability?
  2. 2.Does increasing the elevation angle improve the tolerance of enteral nutrition (tube feeding) while maintaining patient safety?
  3. 3.Be randomly assigned to one of three groups: 10°, 30°, or 45° head-elevated prone position.
  4. 4.Maintain the assigned prone position for at least 12 hours daily.
  5. 5.Undergo monitoring of cardiopulmonary indicators (including oxygen levels, ventilator parameters, blood pressure, and central venous pressure) and digestive function (gastric residual volume) at scheduled intervals (0, 4, 6, and 12 hours).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
102

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 20, 2023

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 8, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 10, 2025

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

December 24, 2025

Completed
14 days until next milestone

First Posted

Study publicly available on registry

January 7, 2026

Completed
Last Updated

January 7, 2026

Status Verified

December 1, 2025

Enrollment Period

2.1 years

First QC Date

December 24, 2025

Last Update Submit

December 24, 2025

Conditions

Outcome Measures

Primary Outcomes (3)

  • Lung Compliance

    Baseline (0 hours), 4 hours, and 6 hours after initiation of prone positioning.

  • Oxygenation Index (OI)

    The Oxygenation Index is a measure used to assess the severity of hypoxic respiratory failure and lung function recovery. It is calculated using the formula: OI = (FiO2 × Mean Airway Pressure × 100) / PaO2. Arterial blood gases (PaO2) are obtained from arterial lines, and FiO2 and mean airway pressure are recorded from the ventilator. Lower scores indicate better oxygenation status.

    Baseline (0 hours), 4 hours, and 6 hours after initiation of prone positioning.

  • Airway Resistance

    Airway resistance is measured by the mechanical ventilator to assess the resistance of the respiratory tract to airflow. Lower values indicate better airway patency and less obstruction. Unit: cmH2O/L/s.

    Baseline (0 hours), 4 hours, and 6 hours after initiation of prone positioning.

Secondary Outcomes (1)

  • Gastric Residual Volume (GRV)

    Baseline (0 hours), 6 hours, and 12 hours after initiation of prone positioning.

Study Arms (3)

10° Head-Elevated Prone Position

EXPERIMENTAL

Participants assigned to this group receive prone positioning therapy with the head of the bed elevated to an angle of 10 degrees. The angle is calibrated using a protractor. The prone position is maintained for at least 12 hours per day.

Procedure: 10° Head-Elevated Prone Positioning

30° Head-Elevated Prone Position

EXPERIMENTAL

Participants assigned to this group receive prone positioning therapy with the head of the bed elevated to an angle of 30 degrees. The angle is calibrated using a protractor. The prone position is maintained for at least 12 hours per day.

Procedure: 30° Head-Elevated Prone Positioning

45° Head-Elevated Prone Position

EXPERIMENTAL

Participants assigned to this group receive prone positioning therapy with the head of the bed elevated to an angle of 45 degrees. The angle is calibrated using a protractor. The prone position is maintained for at least 12 hours per day.

Procedure: 45° Head-Elevated Prone Positioning

Interventions

Participants receive prone positioning therapy with the head of the bed elevated strictly to 10 degrees, verified by a protractor. The position is maintained for at least 12 hours daily. The head position is alternated every 2 hours, and arms are placed alongside the torso.

10° Head-Elevated Prone Position

Participants receive prone positioning therapy with the head of the bed elevated strictly to 30 degrees, verified by a protractor. The position is maintained for at least 12 hours daily. The head position is alternated every 2 hours, and arms are placed alongside the torso.

30° Head-Elevated Prone Position

Participants receive prone positioning therapy with the head of the bed elevated strictly to 45 degrees, verified by a protractor. The position is maintained for at least 12 hours daily. The head position is alternated every 2 hours, and arms are placed alongside the torso.

45° Head-Elevated Prone Position

Eligibility Criteria

Age0 Years - 14 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Congenital Heart Disease (CHD) confirmed by echocardiography with surgery performed.
  • RACHS-1 score ≥ 2.
  • Postoperative acute hypoxemia, defined as PaO2/FiO2 ≤ 100 mmHg with bilateral infiltrates.
  • Receiving invasive mechanical ventilation.
  • Nasogastric or nasoenteric tube in place.
  • Hemodynamic stability for ≥ 72 hours (inotropic score ≤ 25).

You may not qualify if:

  • Cardiac arrest or age-specific bradycardia (\> 20% below normal).
  • Active bleeding.
  • Significant pneumothorax.
  • Delayed sternal closure.
  • Transfer to another facility or death before completing the protocol.
  • Withdrawal of consent by legal guardians.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Guangdong Provincial People's Hospital

Guangzhou, Guangdong, 510080, China

Location

MeSH Terms

Conditions

Heart Defects, CongenitalHypoxiaRespiratory InsufficiencyPostoperative Complications

Condition Hierarchy (Ancestors)

Cardiovascular AbnormalitiesCardiovascular DiseasesHeart DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesSigns and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and SymptomsRespiration DisordersRespiratory Tract DiseasesPathologic Processes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
people processing the numbers (statisticians) and recording the numbers (data collectors)
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 24, 2025

First Posted

January 7, 2026

Study Start

April 20, 2023

Primary Completion

May 8, 2025

Study Completion

July 10, 2025

Last Updated

January 7, 2026

Record last verified: 2025-12

Locations